Mitotic inhibitors
What are Mitotic inhibitors
Mitotic inhibitors are drugs derived from natural plant sources. They inhibit cell division or mitosis, where a single cell divides into two genetically identical daughter cells. Mitotic inhibitors bind to tubulin and inhibit its polymerization into microtubules. Microtubules are structures responsible for pulling the cell apart when it divides. Mitotic inhibitors affect cancer cells more than normal cells because cancer cells divide (mitotic cell division) more rapidly therefore are more susceptible to mitotic inhibition.
Different mitotic inhibitors are used to treat particular types of cancers, such as leukemia, lymphoma, breast cancer, lung cancer and other types of cancers.
List of Mitotic inhibitors:
See also...
Medical conditions associated with mitotic inhibitors:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Anaplastic Oligodendroglioma
- Breast Cancer
- Breast Cancer, Adjuvant
- Breast Cancer, Metastatic
- Cancer
- Choriocarcinoma
- Diffuse Large B-Cell Lymphoma
- Evan's Syndrome
- Gastric Cancer
- Head and Neck Cancer
- Histiocytosis
- Hodgkin's Lymphoma
- Kaposi's Sarcoma
- Liposarcoma
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Mycosis Fungoides
- Neuroblastoma
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rhabdomyosarcoma
- Small Cell Lung Cancer
- Solid Tumors
- Testicular Cancer
- Wilms' Tumor